User Settings
Open AccessReview10.3238/arztebl.2015.0452

The Treatment of Well-Differentiated Thyroid Carcinoma

Ralf Paschke,Thomas Lincke,Stefan Müller,Michael C. Kreißl,Henning Dralle,Martin Faßnacht-2015-06-26-Deutsches Ärzteblatt international
64

TL;DRAbstract

Slow tumor growth, good resectability, and susceptibility to radioactive iodine therapy lend a favorable prognosis to most cases of well-differentiated thyroid carcinoma. The treatment should be risk-adjusted and interdisciplinary, in accordance with the current treatment guidelines. Even metastatic thyroid carcinoma has a favorable prognosis as long as there is good iodine uptake. The newly available medical treatment options for radioactive-iodine-resistant disease need to be further studied.

Chat with Paper

AI Agents for this Paper

Slow tumor growth, good resectability, and susceptibility to radioactive iodine therapy lend a favorable prognosis to most cases of well-differentiated thyroid carcinoma. The treatment should be risk-adjusted and interdisciplinary, in accordance with the current treatment guidelines. Even metastatic thyroid carcinoma has a favorable prognosis as long as there is good iodine uptake. The newly available medical treatment options for radioactive-iodine-resistant disease need to be further studied.

Keywords

MedicineThyroid carcinomaThyroidInternal medicineThyroid cancerIncidence (geometry)OncologyCarcinoma

Chat

Click to start Chat